Over the next three years and with a nearly $1 million grant from the National Institute of Neurological Disorders and Stroke, UK researchers are studying whether a rapid blood test could serve as another means of support in diagnosing concussion.
This strategic collaboration, which includes UK's Office of Technology Commercialization and a pharmacy researcher at UK, involves R&D for US WorldMeds’ investigational product, lofexidine.
This article provides results from focus groups and interviews conducted with 138 patients and 110 family caregivers from California, Colorado, Kentucky, Louisiana, New England, and Pennsylvania.
Postdoctoral researchers and graduate students from all disciplines are invited to present posters and oral presentations, with a chance to win cash prizes. The deadline to submit an abstract for a poster presentation is Friday, May 18.
LUXFER MEL Technologies, a global producer and supplier of inorganic materials, has licensed technology from the UK Center for Applied Energy (UK CAER) that shows great promise in reducing vehicle emissions.
Healthcare professionals and researchers from UK HealthCare, UK College of Nursing, and Eastern State Hospital partnered to share resources dedicated to improving research and patient outcome.
With a $4.9 million contract from the Patient-Centered Outcomes Research Institute (PCORI), the University of Kentucky will expand and improve treatment for pregnant women with opioid use disorder (OUD) in rural areas of Kentucky through the PATHways program.
Kentucky Geological Survey will welcome to the UK campus approximately 100 geoscientists, cartographers and GIS professionals to attend the Digital Mapping Techniques conference later this May.
New findings from the University of Kentucky published in the Journal of Neuroscience demonstrate that there may be ways to address blood-brain barrier dysfunction in epilepsy.
